• CTX001 to Be Developed as Gene-Editing Therapy for Sickle Cell Disease
  • Intellia Uses Gene Editing to Replace Defective Blood Component in Sickle Cell Disease
  • Sickle Cell Disease Patients Use Opioids More When Experiencing Negative Emotions, Study Finds
  • New Online Platform Created to Support Sickle Cell Disease Community
  • Teen with Sickle Cell Disease Takes Class Trip to Europe with Loyola Medicine’s Help
  • Expert Analysis Updates Advice on Managing Sickle Cell Retinopathy
  • Review Board Finds Global Blood’s Sickle Cell Disease Therapy Voxelotor Is Safe
  • Rare Disease Patient Groups Unite to Preserve Orphan Drug Tax Credit in US
  • Increase in a Type of Gut Bacteria Linked to More Pain in Patients with Sickle Cell Disease
  • Sickle Cell Patient with Severe Anemia Rapidly Improves with Voxelotor, Case Study Shows
  • Alzheimer’s Treatment Memantine Shows Promise in Treating Sickle Cell Disease
  • Investigational Therapy Altemia Achieves Main Endpoints in Pediatric Sickle Cell Trial